Medicared For All Logo

Richard Lee MD in Rockville Centre, New York

Home New York Rockville Centre

Richard Lee MD has Hematology/oncology as his primary medical specialty. Their primary office is: 242 Merrick Rd in Rockville Centre, New York.

They're a part of the: Mount Sinai School Of Medicine medical group which has around 139 members. You can call their office at 516-536-1455 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Miami, Lm Miller School Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.


Richard M Lee MD Office Phone and Directions

Richard Lee MD
Mount Sinai School Of Medicine
242 Merrick Rd
Rockville Centre, New York 11570
516-536-1455


Patient Ratings
Please rate your experience with Richard Lee MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 516-536-1455


Enter a starting address:


Healthcare Info for Richard Lee MD

Medical School: University Of Miami, Lm Miller School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Richard Lee MD is listed as: Hematology/oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 6507858289
NPI #: 1033118229
NPI Created On: 07/19/2005
NPI Last Updated Listed as: 03/09/2017
Primary Taxonomy Code: 207RH0003X
License Number:
2287131
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Bone marrow biopsy and aspiration
  3. Complete blood cell count (red cells, white blood cell, platelets), automated test
  4. Blood test, clotting time
  5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  6. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  7. Therapeutic removal of whole blood to correct blood level imbalance
  8. New patient office or other outpatient visit, typically 45 minutes
  9. New patient office or other outpatient visit, typically 60 minutes
  10. Established patient office or other outpatient visit, typically 15 minutes
  11. Established patient office or other outpatient, visit typically 25 minutes
  12. Established patient office or other outpatient, visit typically 40 minutes
  13. Initial hospital inpatient care, typically 50 minutes per day
  14. Initial hospital inpatient care, typically 70 minutes per day
  15. Subsequent hospital inpatient care, typically 25 minutes per day
  16. Physician telephone patient service, 11-20 minutes of medical discussion
  17. Physician telephone patient service, 21-30 minutes of medical discussion
  18. Injection, darbepoetin alfa, 1 microgram (non-esrd use)
  19. Injection, denosumab, 1 mg
  20. Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832143569

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832143595

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783480831

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $17

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783480841

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834965189

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HORMONE THERAPY

Name of Drug #1: ORGOVYX

Open Associated Drug #1: 72974-120-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 834965187

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: HORMONE THERAPY

Name of Drug #1: ORGOVYX

Open Associated Drug #1: 72974-120-01


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813020311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813020327

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: TABRECTA

Name Of Drug #3: 0078-0709-56


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813020315

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: LUTATHERA

Open Associated Drug #1: 69488-003-01


Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813020319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: PROMACTA

Open Associated Drug #1: 0078-0686-15

Drug or Biological: Drug

Product Category #2: HEMATOLOGY

Name Of Drug #2:: RYDAPT

Associated Drug #2: 0078-0698-19


Hematology/oncology Professionals in Rockville Centre

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

242 Merrick Rd
Rockville-centre, NY
Mount Sinai School Of Medicine

Providers in Mount Sinai School Of Medicine

1.Anubhav Agarwal

196 Merrick Rd
Oceanside Ny 11572-1420
Mount Sinai School Of Medicine
Family Practice

2.David Aharonoff

242 Merrick Rd
Rockville Centre Ny 11570-5254
Mount Sinai School Of Medicine
Neurology

3.David Aharonoff

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Neurology

4.Imtiaz Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Internal Medicine

5.Muhammad Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Pulmonary Disease

6.Muhammad Ahmad

1 Healthy Way
Oceanside Ny 11572-1551
Mount Sinai School Of Medicine
Pulmonary Disease

View all 139 members of Mount Sinai School Of Medicine medical group